Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature

ZENG Pei-pei, HUANG Li-ping, DENG Liang-qiong, FENG Yu-shan, XIONG Li, ZENG Ting, LI Hong-hui

Chinese Journal of Child Health Care ›› 2021, Vol. 29 ›› Issue (1) : 71-74.

PDF(453 KB)
PDF(453 KB)
Chinese Journal of Child Health Care ›› 2021, Vol. 29 ›› Issue (1) : 71-74. DOI: 10.11852/zgetbjzz2020-1695
Clinical Research

Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature

  • ZENG Pei-pei, HUANG Li-ping, DENG Liang-qiong, FENG Yu-shan, XIONG Li, ZENG Ting, LI Hong-hui
Author information +
History +

Abstract

Objective To investigate the effect of recombinant human growth hormone therapy on the psychological behavior of children with idiopathic short stature (ISS),in order to provide reference for clinical treatment.Methods From January 2018 to December 2019,a total of 70 children with ISS treated in Liuzhou Maternity and Child Healthcare Hospital were randomly divided into treatment group and control group,with 35 cases in each group.The treatment group was given recombinant human growth hormone 0.15 IU/(kg·d) and injected subcutaneously before bedtime.Both groups received enhanced nutrient supplement,proper exercise,adequate sleep and good mood,and the treatment lasted for 6 months.After the treatment,the score of psychological behavior were compared between two groups.Results After treatment,the scores of split-like,hyperactivity,aggression,violation of discipline factors for boys,(t=4.465,5.053,7.064,5.804,6.815,5.112) body complaint and division forcing factor for girls (t=6.815,5.112) in the treatment group were lower than those before treatment(P<0.05).The scores of split-like,hyperactivity,aggression,violation of discipline factors for boys (t=-3.576,-2.551,-6.100,-2.859),body complaint,social retreat and division forcing factor for girls (t=-7.357,-5.036) in the treatment group were significantly lower than those in the control group after treatment (P<0.05).Conclusions Recombinant human growth hormone therapy can effectively improve some psychological and behavioral problems in ISS children.Recombinant human growth hormone therapy can make the physical and mental development of ISS children more stable and healthy,thus reducing the incidence of psychological and behavioral problems in ISS children.

Key words

recombinant human growth hormone / idiopathic short stature / psychological behavior

Cite this article

Download Citations
ZENG Pei-pei, HUANG Li-ping, DENG Liang-qiong, FENG Yu-shan, XIONG Li, ZENG Ting, LI Hong-hui. Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature[J]. Chinese Journal of Child Health Care. 2021, 29(1): 71-74 https://doi.org/10.11852/zgetbjzz2020-1695

References

[1] 中华医学会儿科分会内分泌遗传代谢学组.矮身材儿童诊治指南[J].中华儿科杂志,2008,46(6):428-430.
[2] Bullinger M,Bloemeke J,Mericq V,et al.Quality of life in adolescent boys with idiopathic short stature:positive impact of growth hormone and aromatase inhibitors[J].Horm Res Paediatr,2018,90(6):381-392.
[3] Cohen LE.Idiopathic short stature:a clinical review[J].JAMA,2014,311(17):1787-1796.
[4] Noeker M.Psychological functioning in idiopathic short stature[J].Horm Res Paediatr,2011,76(3):52-56.
[5] 闫培培,杨玲玲,党晓丽.2015-2017年郑州某医院矮小症患儿焦虑抑郁状况调查[J].预防医学论坛,2019,25(1):39-41.
[6] 陈凌华,赵慧,张素珍,等.矮小症儿童主观生活质量和社会适应能力的研究[J].中国儿童保健杂志,2016,24(12):1271-1273.
[7] Cohen P,Rogol AD,Deal CL,et al.Consensus statement on the diagnosis and treatment of children with idiopath ic short stature:a summary of the Growth Hormone Research Society,the Lawson Wilkins Pediatric Endocrine Society,and the European Society for Paediatric Endocrinology Workshop[J].J Clin Endocrinol Metab,2008,93(11):4210-4217.
[8] 忻仁娥,张志雄,蔡小明,等.全国22个省市26个单位24013名城市在校儿童行为问题凋查—独生子女精神卫生问题的调查、防治和Achenbach's儿童行为量表中国标准化[J].上海精神医学,1992,4(1):47-55.
[9] 苏林燕,李雪荣,罗学荣.Achenbach 儿童行为量表的再标准化及效度检验[J].中国心理卫生杂志,1998,12(2):672-679.
[10] 刘芳,陈俐君,晏世玲.重组人生长激素治疗青春期早期特发性矮小症对骨代谢的影响[J].儿科药学杂志,2019,25(6):26-29.
[11] 沙玉龙.重组人生长激素治疗儿童矮小症的临床效果观察[J].中国冶金工业医学杂志,2020,37(2):204-205.
[12] 中华医学会儿科学分会内分泌遗传代谢学组,《中华儿科杂志》编辑委员会.基因重组人生长激素儿科临床规范应用的建议[J].中华儿科杂志,2013,51(6):426-431.
[13] 吴志华,钟世彪,韦茹,等.不同性别学龄儿童行为问题影响因素分析[J].广州医药,2017,48(1):85-86,91.
[14] 宁曼,何海燕,余敏.儿童心理行为问题及影响因素概述[J].中国妇幼卫生杂志,2017,8(3):4-6,11.
[15] 许露,肖延风,王亚萍,等.身材矮小儿童睡眠饮食和行为问题的病例对照研究[J].中国儿童保健杂志,2020,28(6):664-668.
[16] 朱锦渊,宋娟,农雪艳,等.特发性矮小对不同年龄阶段儿童心理行为的影响[J].中国医学创新,2015,12(23):36-39.
PDF(453 KB)

Accesses

Citation

Detail

Sections
Recommended

/